Page 3 - Ipo Review

RHP analysis: ICICI Prudential AMC flags these top 10 risks ahead of IPO

Here are the top ten risk factors relating to ICICI Prudential Asset Management Company as outlined in its Red Herring Prospectus

Park Medi World IPO: Analysts split on prospects; should you apply?

The three-day subscription window to bid for the Park Medi World IPO will close on Friday, December 12, 2025

Corona Remedies IPO off to a lukewarm start; GMP holds steady at 27%

Corona Remedies IPO: Check price band, lot size GMP, subscription status, reviews, and other key details here

Subscribed to Aequs IPO? Here's how to check allotment status, latest GMP

Once the allotment is finalised, investors who applied for the public offering can check their status on the official websites of BSE, NSE, or Kfin Technologies, the registrar for the issue

Final hours! Heavy NII, retail bidding boosts Meesho IPO; GMP holds steady

Meesho IPO Day 3: Check latest subscription status, grey market premium (GMP), allotment date, listing date, and other key details here

Corona Remedies IPO opens Dec 8: Bid or skip? Here's what experts suggest

Corona Remedies IPO Date: The unlisted shares of Corona Remedies were trading at ₹1,427, commanding a grey market premium of ₹365 or 34.4 per cent on Friday

Wakefit IPO: D2C growth story, key risks ahead, what investors should know

According to the RHP, Wakefit's performance is heavily dependent on its "Wakefit" brand, under which it sells mattresses, furniture and home furnishings

Retail investors drive demand for Aequs IPO on Day 1, NIIs follow; QIBs lag

Retail investors have oversubscribed their reserved portion by 6.42 times, while non-institutional investors (NIIs) have closely followed, with their segment oversubscribed by 1.45 times

Meesho vs Aequs vs Vidya Wires IPO: Which one should you bet on?

Analysts remain largely positive on Meesho IPO and Vidya Wires IPO, citing strong growth prospects and operational efficiency, while views on Aequs IPO are cautious

Meesho IPO opens: From price band to GMP, here's all you need to know

Meesho IPO opens today: Check price band, lot size, GMP, review, allotment date, listing date and other key details here

Willing to apply for Meesho IPO? Check these key risks, strengths from RHP

Investors willing to apply for Meesho IPO can review the company's strengths and risks as outlined in its Red Herring Prospectus (RHP)

Vidya Wires IPO opens tomorrow: Bid or skip? Here's what experts suggest

The unlisted shares of Vidya Wires were trading at ₹57, commanding a grey market premium of ₹5 or 9.6 per cent on Tuesday

Meesho IPO opens Dec 3: Analysts recommend long-term buy; should you bid?

Analysts at SBI Securities and Arihant Capital have recommended that investors subscribe to the Meesho IPO with a long-term perspective.

IPO alert! Madhuri Madhusudan Kela-backed MV Electrosystems files DRHP

Madhuri Kela holds 1.15 million shares, translating into a 5.6 per cent stake, as of the DRHP filing date

'Employee attrition a concern' flags ICICI Pru AMC in DRHP ahead of IPO

The IPO is expected to hit the market in the second half of December and will comprise a complete offer for sale by promoter Prudential Corporation Holdings, which currently holds a 49 per cent stake

Mainboard IPOs take a breather, SME issues to steal spotlight next week

With limited mainboard activity but several SME offerings, the coming week provides selective opportunities for investors looking to participate in the primary markets

Sudeep Pharma IPO sees solid anchor demand, positive GMP; worth your money?

Sudeep Pharma IPO opens for subscription: Check price band, lot size, GMP, reviews, allotment date, listing date, and other key details here

Sudeep Pharma IPO opens Nov 21: Know key strengths, risks before you invest

Sudeep Pharma IPO will be offered at a price band of ₹563 to ₹593 per share

Excelsoft Technologies IPO opens today: Check GMP, price band, key dates

Karnataka-based Excelsoft Technologies raised ₹150 crore from 10 institutional investors via an anchor book on November 18, 2025

Excelsoft Tech IPO opens Nov 19: Bid or skip? Here's what experts suggest

SBI Securities has maintained a 'Neutral' view on the Excelsoft Technologies IPO, while Reliance Securities has assigned a 'Subscribe' rating